(3.143.254.151)
Users online: 11800     
Ijournet
Email id
 

Research Journal of Pharmacognosy and Phytochemistry
Year : 2009, Volume : 1, Issue : 2
First page : ( 98) Last page : ( 102)
Print ISSN : 0975-2331. Online ISSN : 0975-4385.

Momordica Charantia Linn – A Comprehensive Review

Rakesh Sachin U*, Patil Priyanka R, Salunkhe Vijay R

Govt. College of Pharmacy, Karad-415 124, Dist. Satara. (MS) India

*Corresponding Author: Sachin U Rakesh, Govt. College of Pharmacy, Karad-415 124, Dist. Satara. (MS) India Tel: +919823140715; fax: 02164-271196 E-mail: sachinrakesh@rediffmail.com

Online published on 22 March, 2013.

Abstract

Momordica charantia Linn. is a commonly used herb in Ayurvedic medicine. This review supports all updated information on its phytochemical and pharmacological activities, traditional uses and scientific approach. The plant extracts and its chemical marker or target molecule charantin have been widely used for the treatment of a large number of human ailments. The chemical entities of this plant has been used as an antidiabetic, antihelmintic, antimicrobial, hypotriglyceridemic, hypocholesterolemic, insecticidal, antioxidant, anticancer, antimalarial, larvicidal, antiviral, antiulcerogenic agents. Scientifically proved activities are related with traditional concept. Scientific evidence exists with respect to their major and minor constituents. M. charantia is the most important controversial and effective natural origin that has a tremendous future for research. The novelty and applicability of M. charantia are hidden. Such things should be overcome through modern scientific concept.

Top

Keywords

Momordica charantia, Charantin, antidiabetic, Photochemistry, Pharmacological activities.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
809,241,507 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.